Our results suggest that CD38 and PD-L1 are co-expressed in NPC, and some studies suggest that CD38 is positively expressed in patients with non-small cell lung cancer under the condition of PD-L1 resistance 27. Here, CD274 is linked to non-small cell lung carcinoma.